Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
Mutations in the cardiac ryanodine receptor (RYR2) are the leading cause for catecholaminergic polymorphic ventricular tachycardia (CPVT). In this study, we evaluated antiarrhythmic efficacy of carvedilol and flecainide in CPVT patient-specific induced pluripotent stem cell-derived cardiomyocytes (i...
Saved in:
Main Authors: | R. P. Pölönen, K. Penttinen, H. Swan, K. Aalto-Setälä |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2018/9109503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postexertional Supraventricular Tachycardia in Children with Catecholaminergic Polymorphic Ventricular Tachycardia
by: Scott D. N. Else, et al.
Published: (2012-01-01) -
A Homozygous CASQ2 Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia
by: Taishi Fujisawa, et al.
Published: (2019-01-01) -
The Slower, the Better: Wide Complex Tachycardia Triggered by Flecainide in an Elderly Female
by: Ebubechukwu Ezeh, et al.
Published: (2022-01-01) -
Sustained polymorphic ventricular tachycardia in a calf
by: Amir Naseri, et al. -
Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
by: Marisa Ojala, et al.
Published: (2016-01-01)